Your session is about to expire
← Back to Search
Prosthesis
e-OPRA (electronic-Osseoanchored Prosthese for the Rehabilitation of Amputees) for Prosthesis User
N/A
Waitlist Available
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months post-op
Awards & highlights
Study Summary
This study is evaluating whether a new prosthetic device can help people with amputations regain some of the functionality of their missing limbs.
Eligible Conditions
- Prosthesis User
- Neuroma
- Amputation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months post-op
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months post-op
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adverse Events
Change in Electrical signal quality between implanted electrodes and test prosthesis
Secondary outcome measures
Change in Pain Level as measured by DVPRS (Defense and Veterans Pain Rating Scale)
Change in Pain Level as measured by LANSS surveys
Change in Pain Level as measured by PROMIS (Patient Reported Outcomes Measurement Information System) Questionnaire
+7 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Trasnhumeral e-OPRA ImplantExperimental Treatment1 Intervention
This arm includes patients with transhumeral amputation that will receive the e-OPRA implant system.
Find a Location
Who is running the clinical trial?
University of California, San FranciscoOTHER
2,498 Previous Clinical Trials
11,936,348 Total Patients Enrolled
University of MichiganLead Sponsor
1,793 Previous Clinical Trials
6,373,886 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger